Skip to main content

Table 2 Comparison of the clinical presentation outcomes, respiratory function tests, arterial blood gases, and the mean Karnofsky performance score for group A (EBCT+CRT) and group B (CRT) at baseline and follow-up after the procedure

From: The value of endobronchial cryotherapy in the management of malignant endobronchial obstruction in patients with inoperable NSCLC: a prospective analysis of clinical and survival outcomes

Variable

Group A

Group B

P values I & II

P values

I & III

P values II & IV

P values III & IV

Pre-cryotherapy

(I)

(n=30)

Post-cryotherapy

(II)

(n=30)

Pre-therapy

(III)

(n=30)

Post therapy

(IV)

(n=30)

Clinical presentation

Cough

24 (80%)

6(20%)

24 (80%)

22(73%)

<0.001

1.000

<0.001

0.592

Dyspnea

26 (87%)

6(20%)

28 (93%)

24(80%)

<0.001

0.667

<0.001

0.254

Hemoptysis

30 (100%)

0

28 (93%)

26(87%)

<0.001

0.472

<0.001

0.667

Chest pain

12 (40%)

6(20%)

10 (32%)

8(27%)

0.090

0.592

0.541

0.573

Respiratory function tests

Mean FVC %

62.13±2.8

65±3.65

62.47±1.8

62.53±1.7

0.001

0.578

0.001

0.895

Mean FEV1 %

64.53±3.8

69.87±4.0

65±2.9

65±2.6

<0.001

0.592

<0.001

1.000

Mean 6MWT (m)

262±56

330±76

287±78

292±48

<0.001

0.159

0.024

0.766

Arterial blood gases

Mean PH

7.382±.02

7.385±.01

7.381±.01

7.39±0.03

0.465

0.807

0.390

0.124

Mean So2

87.07±1.8

90.4±1.5

86.7±1.9

87±1.7

<0.001

0.442

<0.001

0.522

Mean PaO2

77.07±1.8

82.9±1.8

76.9±2.4

77.3±2.6

<0.001

0.757

<0.001

0.538

Mean PaCo2

36.9±1.6

41±1.1

37.7±1.8

38.2±1.9

<0.001

0.074

<0.001

0.300

Mean Karnofsky performance score %

57.33±5.67

60.67±6.39

56.87±9.19

56.32±9.63

0.036

0.816

0.044

0.822